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EVOLUTION OF NON-TREATED 
REsTLEss LEgs syNDROmE
Raimundo Nonato Delgado Rodrigues1, Aída Alexandra Alvim de Abreu e Silva Rodrigues2,  
Jorge Faber3, Jeana T. Corso3, Thaisa F. Peixoto4
Abstract – Purpose: The primary concern of this study is to evaluate the clinical course of restless legs syndrome 
(RLS) in a group of patients who refused treatment.  Method: This study compares the outcome of a group of 
RLS patients after one year without any specific treatment. The International Restless Legs Syndrome Scale 
(IRLS) was applied at baseline (irls_1) and after one year (irls_2). The patients answered a simple questionnaire 
for the evaluation of possible environmental or life habit changes after one-year evolution. Serum ferritin was 
determined at baseline. An improvement index (%improvement) was established through the formula: irls_1– 
irls_2/irls_1 × 100. Results were compared and a correlation analysis performed.  Results: A negative significant 
correlation was found between the patientsí age and irls_2 (r= –0.9 p=0.0018) and between %improvement 
and irls_2 (r= –0.88 p=0.0039). A positive and significant correlation was determined between %improvement 
and age. There was only a marginally significant correlation between serum ferritin and ilrs_2 (r= –0.7 p=0.052). 
No significant changes were found in the other elements analyzed.  Conclusion: A favorable outcome was 
found in this group of RLS patients after one year evolution without treatment. The outcome was positively 
influenced by the patientsí age. 
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síndrome das pernas inquietas: evolução após um ano sem tratamento
Resumo – Objetivo: o objetivo deste estudo é avaliar a evolução de oito pacientes com diagnóstico de síndrome 
das pernas inquietas (SPI) após doze meses sem tratamento.  Método: estudo de coorte, retrospectivo, 
consistindo na aplicação da escala de gravidade da SPI (IRLS), de questionário para avaliação de mudanças 
ambientais ou de hábitos de vida e dosagem de ferritina sérica. Realizada comparação da pontuação IRLS 
obtida na consulta inicial (irls_1) e após doze meses de evolução (irls_2) e estabelecido um índice de melhora 
percentual (%melhora=irls_1 – irls_2 / irls_1 × 100). Análise de correlação dos dados obtidos.  Resultados: Foi 
demonstrada correlação negativa e significativa entre a idade e a irls_2 (r= –0,9 e p=0,0018) e entre %melhora 
e irls_2 (r= –0,88 e p=0,0039). encontrou-se correlação positiva e significativa entre %melhora e a idade. 
Houve apenas correlação negativa marginalmente não-significativa entre a dosagem de ferritina sérica e ilrs_2 
(r= –0,7 e p=0,052).  Conclusão: Neste grupo demonstrou-se evolução favorável da SPI após doze meses que 
se correlacionou positivamente com a idade dos pacientes, não tendo sido influenciada aparentemente por 
hábitos de vida ou mudanças ambientais.
PALAVRAS-CHAVe: síndrome das pernas inquietas, IRLS, curso clínico, tratamento, idade.
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Restless legs syndrome (RLS) is a neurological disorder 
characterized by an urge to move the limbs, usually low-
er limbs, sometimes associated with paresthetic sensa-
tions, emerging or worsening with rest or inactivity, which 
symptoms become worse at dusk, with prevalence of 5.5% 
of the general population1,2. However, the practice shows 
that fewer patients are diagnosed and treated than sug-
gested by studies on the prevalence of RLS3. Among the 
reasons for this finding is worth mentioning the low rec-
ognition of the clinical condition by the medical popu-
lation4, which can lead to diagnostic errors5. on the oth-
er hand, patients may also collaborate for the under-di-
agnosis by not realizing or not recognizing the patholog-





Indeed, RLS diagnosis is not easy. A recent population 
study showed that a significant number of patients do 
not seek for medical aid due to the motor condition, but 
rather because of consequences of RLS such as insomnia 
or drop on the quality of life3,4. The diagnostic difficulties 
are exacerbated due to the lack of objective reference 
laboratory testing so far4. Moreover, even in specialized 
centers, the interrogation of patients many times collab-
orates very little for the correct diagnosis because indi-
viduals often have difficulty in describing the symptoms, 
which may even be confused with vascular and position-
al anomalies or even with psychic anxiety7. The presence 
of important genetic component whose expression may 
be delayed or temporally anticipated at every generation 
is another important issue to be considered8,9. The ther-
apeutic management of this condition may be also sub-
jected to discussion since not all patients require medi-
cal treatment4,10. All these issues, however, become even 
more relevant as the natural history of RLS has not been 
adequately described so far. In fact, there are only a few 
studies in literature where this is properly assessed, espe-
cially concerning the moderate or mild forms4,6. 
This study was conducted to investigate the course 
of RLS after twelve months of diagnosis in eight patients 
who, for several reasons, preferred not to undergo the 
pharmacological treatment proposed. Possible environ-
mental, medication or life-style changes that might have 
influenced the evolution were also evaluated. 
mEThOD 
eight patients who fulfilled the international criteria for the 
clinical diagnosis of RLS were included in this study, being 5 fe-
male (62%). All of them, after the diagnosis, made the decision 
not to follow any treatment. Patients had mean age of 50.8±17.4 
years and came primarily from the middle-upper class. As addi-
tional inclusion criteria, there should not be a prior history of 
recent surgery, pregnancy, known disorders of renal function, 
no relevant association to another sleep disorders (sleep apnea 
syndrome, narcolepsy, for example) nor extrapyramidal diseases 
or use of drugs related to the treatment or known for inducing 
movement disorders (antidepressants, dopaminergic, neuroleptic, 
benzodiazepine, anticonvulsants or opioid agents) or use of fer-
ric compounds in the six months prior to admission in the study.
 After the clinical diagnosis of RLS, the patients had respond-
ed a Portuguese version of the International Restless Legs Syn-
drome Rating Scale (IRLS)11 to determine the severity of the clin-
ical condition. 
As part of the RLS diagnosis process, the serum iron and fer-
ritin contents, as well as the transferrin saturation index were 
determined. Additionally, the full blood count and the erythro-
cyte sedimentation rate were performed. It was avoided collect-
ing blood samples during the menstrual period. In this study, on-
ly the serum ferritin content was considered. 
The participants were evaluated in consultation between Ju-
ly and November 2006. All were contacted by phone by two of 
the authors (JTC and TFP) during december 2007. This time, the 
application of the IRLS was once again conducted and the pa-
tients were asked to reply a short questionnaire covering about 
possible changes in some aspects of their lives, habits or environ-
ment that could have influenced the evolution of RLS (Table 1).
Patients were included in the research after informed con-
sent on the purposes of the study and approval by the ethics in-
stitutional committee.
In order to assess the improvement on the IRLS scores ob-
jectively, an arbitrary index (% improvement) was considered, 
being calculated based on the formula: initial IRLS value (irls_1) 
minus the IRLS value after twelve months (irls_2), with results 
being divided by the irls_1 value. The final result was expressed 
as percentage.
The data were analyzed using the SAS V.8.1. software. The de-
scriptive statistics of the dependent and independent variables 
were obtained. A Student paired t test was applied to test the 
hypothesis that there was no difference between IRLS at base-
line and after 12 months without treatment. To access the rela-
tionship of serum ferritin and age at baseline, IRLS at the two 
different moments, and percentage of clinical improvement be-
tween these two moments, a correlation analysis was performed 
(Pearsonís correlation test). The level of significance was estab-
lished at 5%.
REsULTs
The descriptive data of this population can be found 
in Table 2. one of the individuals reported to have start-
ed “treatment for anxiety” in the period but, unfortunate-
ly, he was unable to report the name of the drug or dos-
age used. 
during the study period, the patients reported no sig-
nificant difference in their life habits concerning consump-
tion of alcohol, tobacco, caffeinated beverages, blood do-
nations or shift-work. 
The IRLS questions answered in the initial consultation 
revealed that six patients (75%) had scores that character-
ized severe RLS (>21). The group of eight patients showed 
Table 1. Questionnaire: evolution after twelve months.
were there any changes in the past year in relation to any of the 
following aspects of your life? 
(Identify how was it 1 year ago and how is it now, if possible)
1.  Ingestion of alcohol 
2.  Use of tobacco
3.  Alimentary habits (caffeinated beverages)
4.  Use of new medication 
5.  Blood donation





initial average score of 26.6±10.0 and, after twelve months 
without treatment, 9.25±7.6. This difference was signifi-
cant with p=0.0028. None of the patients at the end of 
the study had scores higher than 21.
The average time elapsed from the initial onset of RLS 
symptoms until the moment of consultation was 7 years.
The dosage of serum ferritin showed average of 
104±76.2 ng/mL (normal range: 29–300 ng/mL). only two 
patients had serum ferritin below 50 ng/mL.
The Pearson test showed a significant negative corre-
lation between age of the population and the final values 
of the IRLS scores (r= –0.9 p=0.0018) and also between the 
improvement percentage and the irls_2 value (r= –0.88 
p=0.0039). A significant positive correlation was found 
between the improvement percentage and age of the 
patients (r=0.89 and p=0.0026). This is equivalent to say 
that the older patients improved more during the twelve-
month period than younger patients (Table 3). 
on the other hand, there was a negative correlation, 
but only marginally significant between serum ferritin and 
irls_2 values (r= –0.7 p=0.052). 
DIscUssION
Most studies seem to suggest that the RLS presents a 
chronic natural course that tends to worsen with age until 
at least the age of 60 years6. on the other hand, there may 
be total remission of symptoms, even for a few months 
only, in up to 15% of cases, regardless of the therapy. In-
deed, the literature recognizes that the long-term evo-
lution is still unknown mainly in the mild to moderate 
forms3,6,7. The RLS patients with severe clinical course are, 
however, more easily diagnosed in primary care settings5. 
on the other hand, it is known that patients with RLS 
often do not seek medical aid despite presenting intense 
symptoms6, and even when they do, they may still be un-
der-diagnosed, since the RLS, out of specialized centers, 
is usually not recognized or considered as a significant 
health disorder4. In a recent study, walters et al. reported 
that in a cohort of 140 RLS patients interviewed, 22% did 
not believe that they had a treatable condition12. 
The patients included in this study reported motor 
symptoms characteristic of RLS. All patients belonged 
to the middle-upper class, and were mostly profession-
als and civil servants, with excellent educational level. 










1 25 7 years no 38.3 18 18 0
2 54 6 years no 215 24 7 70.8
3 30 14 days sinvastatin 51.8 38 21 44.7
4 56 5 years no 99.2 26 9 65.9
5 41 12 years trazodone 17.9 29 12 58.6
6 66 10 years no 66.1 34 7 79.4
7 59 6 years “anxyolitic” 132 36 0 100
8 75 10 years enalapril 212 8 0 100 
irls_1, initial IRLS score; irls_2, IRLS score after twelve months; %improvement, irls_1 – irls_2 / irls_1 × 100
Table 3. Results of the correlation test (Pearson).






















































Moreover, 75% of them had severe RLS score range and 
had motor complaints for 7 years on average, which, at 
least in theory, suggested a significant impact on daily 
life. Nevertheless, after the initial diagnostic workup, they 
refused any pharmacological treatment and did not return 
to subsequent consultations, giving several excuses. In the 
study conducted by walters et al. 9% of the patients also 
gave several excuses for not seeking early treatment12. 
despite the refusal of treatment, when contacted 
approximately twelve months after the diagnosis, all 
patients but one reported significant improvement ex-
pressed in the drop of the IRLS scores (p=0.0028), two of 
them being totally asymptomatic. This finding is interest-
ing, since it by far surpasses the “few months” of remission 
reported in literature7,12. 
The explanation of these results certainly cannot be 
found in changes in lifestyle or environment, at least on 
items evaluated, since there were no reports of significant 
change in the consumption of alcohol, tobacco, caffein-
ated beverages, blood donations or shift-work1,6. 
No specific medication for RLS was used during the 
study period. one of the patients, however, used tra-
zodone that may have contributed for sleep induction 
although not considered useful in the treatment of tradi-
tional forms of RLS. Similarly, it is not possible to analyze 
objectively the influence of the “anxiolytic” treatment 
used by another individual from the group since we have 
no details concerning the type of substance used or the 
dosing regimen or frequency.
The results of this study show a significant negative 
correlation between age and IRLS scores obtained after 
twelve months (r= –0.9 p=0.0018), suggesting that older 
patients finished this period with fewer points in the ques-
tionnaire. A significant positive correlation between age 
and the percentage of improvement obtained (r=0.89 and 
p=0.0026) was also verified, suggesting that older patients 
had better evolution of motor symptoms than younger 
patients in the study period. 
It is known that patients who begin to present RLS at 
more advanced ages in general tend to develop symp-
toms faster, not showing a clear distinction between age 
and severity of the clinical condition13. on the other hand, 
patients who begin to present RLS earlier in life tend to 
present the motor symptoms in an intermittent and insid-
ious way in the beginning, but with progressive worsening, 
until 40 to 60 years-old when the symptoms may occur 
daily4. Most patients in this study apparently developed 
RLS symptoms above 50 years of age, which could have 
led to a rapid initial evolution, followed by a stabilization 
trend later. Such possibility has already been suggested in 
clinical course studies of patients with very tardive mani-
festation of RLS or Parkinson’s disease6.
Serum ferritin levels showed marginally significant neg-
ative correlation with the IRLS scores after twelve months 
(r= –0.7 p=0.052). we believe that the small sample used 
in this study prevented us from analyzing properly this 
result. However, since the serum ferritin is usually con-
sidered a good marker of organic iron supplies14, it would 
be instigating to infer in this group that the pre-existence 
of good iron supply (brain) could be correlated with the 
favorable RLS development in the study period. 
on the other hand, our results admit several consid-
erations. obviously, it is not possible to reject the inad-
equate filling of the IRLS or misunderstanding of its ques-
tions by the patients, despite the training and performance 
of the team responsible for the clinical research, since it 
is a common problem with the use of questionnaires in 
general. However, IRLS used in population studies have 
already demonstrated acceptable sensitivity and specific-
ity degree15. The telephone interview has been used in the 
application of questionnaires in epidemiological research 
of RLS with no damage to the sensitivity or specificity of 
the instrument used15. 
Finally, the small number of patients studied, which is 
a clear statistical disadvantage, and the absence of long-
term evolution studies, prevented us from investigating 
the hypothesis that RLS could spontaneously improve or 
even disappear, either definitively or for many consecutive 
years and not only for “a few months”. obviously, these re-
sults need to be confirmed by studies that would include 
more individuals, higher number of variables rigorously 
examined (not just environmental but also biochemical 
and clinical ones) and duration above twelve months. Sim-
ilarly, more studies on the clinical course of RLS should be 
conducted in order to better characterize the natural evo-
lution of mild and moderate forms of RLS and to deter-
mine their true impact on the quality of life of patients, 
important factors to indicate the real need for treatment.
In summary, these data suggest that in this group of 
untreated RLS patients (75% of individuals with the severe 
form), the natural evolution of the clinical condition in 
12 months was favorable, with significant improvement 
measured through IRLS. This improvement is positively 
correlated with age and apparently not associated to any 
environmental changes or life habits.
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